Press Room

2023 CPhI North America

Start
Tuesday, April 25, 2023 - 00:00
End
Thursday, April 27, 2023 - 00:00
Location: Philadelphia, USA
Booth Number: 723
The Leader in Spray Drying | Hovione

Visit Hovione at CPhI North America - Booth #723 - and discover more about the latest technologies and innovations in drug development.

 

Continuous Tableting for your drug product. The future is continuous | Hovione

The Future is Continuous

Meet our experts and find out if Continuous Tableting is right for your product.

ASD-HIPROS | Hovione

ASD-HIPROS

Learn how this platform can identify the best performing and stable formulations for your drug.

Hovione, The Leader in Spray Drying | Hovione

The Leader in Spray Drying

Know how to improve your drug solubility with the best scale-up science.

Click here and Get in touch today | Hovione

Schedule a meeting today

We look forward to seeing you at CPhI North America and support your project.

 

 

Let’s discuss your project together.

schedule a meeting

 

 

 

Schedule a meeting with our experts.

 

Find more about CPhI North America.

Also in the Press Room

See All

Lisbon, Portugal – Hovione, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, Hovione joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At Hovione, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of Hovione. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” Hovione will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with Hovione’s sustainability ambitions.  Hovione remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024